Integrin β3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population

Pharmacogenetics and Genomics

Volumn 17, Issue 1, 2007, Pages 85-91

  Tofteng, Charlotte L ^a   Bach Mortensen, Pernille ^a   Bojesen, Stig E ^b   Tybjærg Hansen, Anne ^c,d   Hyldstrup, Lars ^a   Nordestgaard, Børge G ^b,c  

^a HVIDOVRE HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Association; Fracture; Genetic polymorphism; Integrin 3; Population study

Indexed keywords

BETA3 INTEGRIN; LEUCINE; PROLINE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENMARK; FEMALE; FOLLOW UP; GENETIC RISK; GENOTYPE; HAZARD RATIO; HETEROZYGOTE; HIP FRACTURE; HOMOZYGOTE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; POPULATION RISK; POSTMENOPAUSE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZATION; RISK ASSESSMENT; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; AMINO ACID SUBSTITUTION; BONE DENSITY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; BONE DENSITY; DENMARK; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIP FRACTURES; HOMOZYGOTE; HUMANS; INTEGRIN BETA3; LEUCINE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROLINE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33846572215     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/01.fpc.0000236327.80809.f8     Document Type: Article

References (27)

1. Ralston SH. Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 2002; 87:2460-2466.
2. Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med 1998; 338:736-746.
3. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001; 285:785-795.
4. Delmas PD. Treatment of postmenopausal osteoporosis. Lancet 2002; 359:2018-2026.
5. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289:1504-1508.
6. van der Flier A, Sonnenberg A. Function and interactions of integrins. Cell Tissue Res 2001; 305:285-298.
7. Teitelbaum SL. Osteoclasts, integrins, and osteoporosis. J Bone Miner Metab 2000; 18:344-349.
8. Murphy MG, Cerchio K, Stoch SA, Gottesdiener K, Wu M, Recker R. Effect of L-000845704, an alphaVbeta3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. J Clin Endocrinol Metab 2005; 90:2022-2028.
9. Honda S, Honda Y, Bauer B, Ruan C, Kunicki TJ. The impact of three-dimensional structure on the expression of PlA alloantigens on human integrin beta 3. Blood 1995; 86:234-242.
10. Vijayan KV, Goldschmidt-Clermont PJ, Roos C, Bray PF. The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions. J Clin Invest 2000; 105:793-802.
11. Feng D, Lindpaintner K, Larson MG, Rao VS, O'Donnell CJ, Lipinska I, et al. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999; 19:1142-1147.
12. The Copenhagen City Heart Study. Østerbroundersøgelsen. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-83). The Copenhagen City Heart Study Group. Scand J Soc Med Suppl 1989; 41:1-160.
13. Schnor P, Jensen G, Lange P, Scharling H, Appleyard M. The Copenhagen City Heart Study. Østerbroundersøgelsen, tables with data from the third examination 1991-1994. Eur Heart J Suppl 2001; 3:H1-H83.
14. Bojesen SE, Juul K, Schnohr P, Tybjaerg-Hansen A, Nordestgaard BG. Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study. J Am Coll Cardiol 2003; 42:661-667.
15. Hoidrup S, Gronbaek M, Gottschau A, Lauritzen JB, Schroll M. Alcohol intake, beverage preference, and risk of hip fracture in men and women. Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 1999; 149:993-1001.
16. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: scientific review. JAMA 2002; 288:1889-1897.
17. Lips P. Epidemiology and predictors of fractures associated with osteoporosis. Am J Med 1997; 103:3S-8S.
18. Conference Report. Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med 1991; 90:107-110.
19. Bouxsein ML, Palermo L, Yeung C, Black DM. Digital X-ray radiogrammetry predicts hip, wrist and vertebral fracture risk in elderly women: a prospective analysis from the study of osteoporotic fractures. Osteoporos Int 2002; 13:358-365.
20. Michelson AD, Furman MI, Goldschmidt-Clermont P, Mascelli MA, Hendrix C, Coleman L, et al. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 2000; 101:1013-1018.
21. Di Castelnuovo A, de Gaetano G, Donati MB, Iacoviello L. Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis. Thromb Haemost 2001; 85:626-633.
22. Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. Integrin beta3 Leu33Pro homozygosity and risk of cancer. J Natl Cancer Inst 2003; 95:1150-1157.
23. Davoren A, Curtis BR, Aster RH, McFarland JG. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004; 44:1220-1225.
24. Guo XE, Kim CH. Mechanical consequence of trabecular bone loss and its treatment: a three-dimensional model simulation. Bone 2002; 30:404-411.
25. Michaelsson K, Melhus H, Ferm H, Ahlbom A, Pedersen NL. Genetic liability to fractures in the elderly. Arch Intern Med 2005; 165:1825-1830.
26. Andrew T, Antioniades L, Scurrah KJ, Macgregor AJ, Spector TD. Risk of wrist fracture in women is heritable and is influenced by genes that are largely independent of those influencing BMD. J Bone Miner Res 2005; 20:67-74.
27. Tofteng CL, Jensen JE, Abrahamsen B, Odum L, Brot C. Two polymorphisms in the vitamin D receptor gene-association with bone mass and 5-year change in bone mass with or without hormone-replacement therapy in postmenopausal women: the Danish Osteoporosis Prevention Study. J Bone Miner Res 2002; 17:1535-1544.